Clinical Trials Directory

Trials / Completed

CompletedNCT02453152

Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
University of Florida · Academic / Other
Sex
Male
Age
14 Years
Healthy volunteers
Not accepted

Summary

This study is a longitudinal study evaluating the severity and progression of respiratory muscle function in patients with X-Linked Myotubular Myopathy (XLMTM) aged 0-14.

Detailed description

Subjects aged 0-7 will be evaluated every six months for a total of three evaluations (Baseline, Six-Month Visit, Twelve-Month Visit). Subjects aged 8-14 will be evaluated every twelve months for a total of two evaluations (Baseline, Twelve-Month Visit). Evaluations include medical history, physical exam, respiratory muscle tests, a qualitative interview related to the child's function and use of respiratory aids, and quality of life assessments.

Conditions

Interventions

TypeNameDescription
OTHERHistory and physicalSubjects will undergo a physical exam and medical history review, including review of genetic test results.
OTHERTidal breathingSubjects' breathing patterns will be evaluated at rest and at reduced/eliminated ventilator support.
OTHERMaximal respiratory pressuresSubjects' strongest inspiratory and expiratory pressures will be measured.
OTHERPeak cough flowSubjects' strongest coughs will be measured.
OTHERPediatric Evaluation of Disability InventoryAssesses the functional capabilities of children with disabilities.
OTHERPedsQL Multidimensional Fatigue ScaleAssesses general fatigue, sleep/rest fatigue, and cognitive fatigue.
OTHERReview of ventilation requirementsSubjects's use of mechanical ventilation reviewed by the study team.

Timeline

Start date
2015-10-01
Primary completion
2019-07-31
Completion
2019-07-31
First posted
2015-05-25
Last updated
2021-02-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02453152. Inclusion in this directory is not an endorsement.